Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mikhail Brovko, Lidia Kozlovskaya, Andrey Pulin, Sergey Moiseev, Victoria Sholomova, Dmitry Shchekochikhin, Daria Gognieva, Ludmila Milovanova & Victor Fomin. (2018) Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect. International Journal of Nephrology and Renovascular Disease 11, pages 271-277.
Read now
Read now
Solveig Klok Matthesen, Thomas Larsen, Thomas Guldager Lauridsen, Henrik Vase, Pia Holland Gjørup, Karen Marie Nykjær, Søren Nielsen & Erling Bjerregaard Pedersen. (2012) Effect of Amiloride and Spironolactone on Renal Tubular Function, Ambulatory Blood Pressure, and Pulse Wave Velocity in Healthy Participants in a Double-Blinded, Randomized, Placebo-Controlled, Crossover Trial. Clinical and Experimental Hypertension 34:8, pages 588-600.
Read now
Read now
J. Starklint, J. N. Bech, O. Nyvad, P. Jensen & E. B. Pedersen. (2006) Increased urinary aquaporin‐2 excretion in response to furosemide in patients with chronic heart failure. Scandinavian Journal of Clinical and Laboratory Investigation 66:1, pages 55-66.
Read now
Read now
Articles from other publishers (7)
Frank Holden Mose, Anna Ewa Oczachowska‐Kulik, Robert Andrew Fenton & Jesper Nørgaard Bech. (2020) Effect of furosemide on body composition and urinary proteins that mediate tubular sodium and sodium transport—A randomized controlled trial. Physiological Reports 8:24.
Crossref
Crossref
F. H. Mose, A. N. Jörgensen, M. H. Vrist, N. P. Ekelöf, E. B. Pedersen & J. N. Bech. (2019) Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects – a randomized controlled trial. BMC Nephrology 20:1.
Crossref
Crossref
Troels M Busk, Søren Møller, Erling B Pedersen, Alexander Gerbes, Aleksander Krag, Markus Peck-Radosavljevic, Sona Frankova, Minneke J Coenraad & Flemming Bendtsen. (2017) Aquaporin-2 excretion in hospitalized patients with cirrhosis: Relation to development of renal insufficiency and mortality. Journal of Gastroenterology and Hepatology 32:5, pages 1087-1093.
Crossref
Crossref
Xiaohua HuangEvert Dorhout MeesPieter Vos, Shereen Hamza & Branko Braam. (2016) Everything we always wanted to know about furosemide but were afraid to ask. American Journal of Physiology-Renal Physiology 310:10, pages F958-F971.
Crossref
Crossref
Zhen-Li Wu, Hao Ren, Wen-Yan Lai, Sheng Lin, Rong-Yan Jiang, Tao-Chun Ye, Qian-Bo Shen, Qing-Chun Zeng & Ding-Li Xu. (2014) Sclederma of Poria cocos exerts its diuretic effect via suppression of renal aquaporin-2 expression in rats with chronic heart failure. Journal of Ethnopharmacology 155:1, pages 563-571.
Crossref
Crossref
Susan E Shoaf, Steven L Bramer, Patricia Bricmont & Christopher A Zimmer. (2007) Pharmacokinetic and Pharmacodynamic Interaction Between Tolvaptan, a Non-Peptide AVP Antagonist, and Furosemide or Hydrochlorothiazide. Journal of Cardiovascular Pharmacology 50:2, pages 213-222.
Crossref
Crossref
Christina Esteva-Font, Maria E. Baccaro, Patricia Fernández-Llama, Laia Sans, Monica Guevara, Elisabet Ars, Wladimiro Jiménez, Vicente Arroyo, Jose A. Ballarín & Pere Ginès. (2006) Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome. Hepatology 44:6, pages 1555-1563.
Crossref
Crossref